HSE agrees to fund drug for patients with Friedreich’s ataxia
Omaveloxolone, branded as Skyclarys, has been approved in US and Europe for treatment of disease
See all — The Irish Times →Aggregated from the leading newsrooms of the country. Every story links to its original source.







